Growth Disorders
📧 Sign up to get email alerts when something new happens for Growth Disorders.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-26EMA Authorised: Vijoice (alpelisib) — Novartis Europharm Limited
EMA authorised Vijoice (alpelisib) by Novartis Europharm Limited with conditional approval for genetic diseases of growth disorders; orphan …
-
EMA approval · 2026-08-21EMA Authorised: Ngenla (somatrogon) — Pfizer Europe MA EEIG
Ngenla (somatrogon) has been authorized by the EMA for growth and development indications in the European Union.